logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12121540 B1

PDFFull Text
Date of Patent:
Oct. 22, 2024

Filed:

Sep. 23, 2020

Cbl inhibitors and compositions for use in adoptive cell therapy

Applicant:

Nurix Therapeutics, Inc., San Francisco, CA (US);

Inventors:

Jennifa Gosling, San Francisco, CA (US);

Arthur Sands, San Francisco, CA (US);

Sarah Anne Whelan, San Francisco, CA (US);

Cristiana Guiducci, San Francisco, CA (US);

Assignee:

NURIX THERAPEUTICS, INC., San Francisco, CA (US);

Attorney:

SQUIRE PATTON BOGGS (US) LLP

Primary Examiner:

Julie Wu

Assistant Examiner:

John J Skoko, Iii

Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61K 31/4196 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 31/4196 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); A61P 37/04 (2018.01); C12N 5/0636 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/2307 (2013.01); C12N 2501/2315 (2013.01); C12N 2501/2321 (2013.01); C12N 2501/72 (2013.01); C12N 2506/11 (2013.01);
Abstract

Methods and compositions using novel Cbl inhibitors for supporting engraftment of immune cells to increase the efficacy of cell-based immunotherapeutics are disclosed. Also provided are cell-based immunotherapy methods and compositions using novel Cbl inhibitors for the propagation of cells desirable for use in cell-based immunotherapies.

Find Patent Forward Citations

Gosling, Jennifa. (2024). Cbl inhibitors and compositions for use in adoptive cell therapy (U.S. Patent No. 12121540). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12121540

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…